Bluepearl Seeds is Morocco’s first certified seed producer specialising in high-performance cannabis and hemp genetics for industrial, pharmaceutical, and medical supply chains.
We develop, produce, and supply certified seeds in bulk to licensed operators worldwide— combining genetic excellence with full regulatory compliance.
Bluepearl Seeds supplies certified cannabis and hemp seeds exclusively to
Certified farmers and agricultural cooperatives operating under regulated agricultural frameworks.
Industrial hemp cultivation operations focused on fiber, grain, and cannabinoid production.
Licensed CBD and CBG flower producers supplying premium-grade cannabinoid crops.
Extraction and biomass-focused growers serving large-scale processing and refinement markets.
Pharmaceutical and medical cannabis operators meeting strict quality and compliance standards.
Our genetics are designed to meet the demands of regulated cultivation systems, whether the goal is premium flower, high-yield biomass, or pharmaceutical-grade raw material.
After Morocco’s cannabis legalisation in 2023, Bluepearl Seeds committed to an intensive two-year global R&D program, sourcing elite CBD and CBG genetics from leading hemp regions worldwide.
Through controlled breeding, stabilisation, and field testing, we have developed four flagship cultivars selected for:
Each variety is bred for reliability at scale, season after season.
At Bluepearl Seeds, compliance is not an afterthought—it is built into every stage of production.
Our varieties are inscribed on the national list, supporting acceptance across most regulated jurisdictions worldwide, subject to local import regulations.
Bluepearl Seeds genetics are suitable for:
All genetics are developed with a focus on controlled cannabinoid expression, genetic stability, and regulatory compatibility, enabling integration into GACP- and GMP-aligned production systems where required.
Morocco offers a unique combination of:
This allows Bluepearl Seeds to produce high-quality certified seeds at commercial scale, while maintaining strict regulatory oversight.
